to DSBs during replication and these DSBscan leadto DSBs during replication and these DSBs
to to DSBs during replicationcan contributeto to DSBs during replication
to DSBs during replicationcan leadto DSBs during replication
to DSBscan leadto DSBs
to DSBscan contributeto DSBs
from inhibition of repair enzymes at levels of 5 to 100 mm in human epithelial type ii cellsresultingfrom inhibition of repair enzymes at levels of 5 to 100 mm in human epithelial type ii cells
to gene mutations that cause cancercan ... leadto gene mutations that cause cancer
immediately after IR treatmentresultingimmediately after IR treatment
chromosome breakage , which can contribute to genetic disorders and intergenerational diseasecan causechromosome breakage , which can contribute to genetic disorders and intergenerational disease
, one after the othermay result, one after the other
alsomay ... resultalso
to cell deathleadingto cell death
to carcinogenesis , mutagenesis and cytotoxicityleadingto carcinogenesis , mutagenesis and cytotoxicity
to carcinogenesis , mutagenesis and cytotoxicitycontributeto carcinogenesis , mutagenesis and cytotoxicity
to carcinogenesis , mutagenesis , and cytotoxicitycontributesto carcinogenesis , mutagenesis , and cytotoxicity
to carcinogenesis , mutagenesis and cytotoxicity ... 26].contributesto carcinogenesis , mutagenesis and cytotoxicity ... 26].
in genome instability and tumor formation during agingcan resultin genome instability and tumor formation during aging
to non - homologous endleadingto non - homologous end
to chromosome rearrangementscould leadto chromosome rearrangements
to cell mutationsleadingto cell mutations
to cell deathleadsto cell death
in cell deathwill resultin cell death
in cell deathresultin cell death
to the cell deathleadingto the cell death
to cell deathleadingto cell death
in cell cycle arrest and [ [ apoptosisresultin cell cycle arrest and [ [ apoptosis
to the rearrangement of DNAcan leadto the rearrangement of DNA
to oncogenic translocation and gene amplificationleadingto oncogenic translocation and gene amplification
to cancerleadingto cancer
to cell death , mutation , or carcinogenesiscan leadto cell death , mutation , or carcinogenesis
genome rearrangements , such as deletions , duplications , and translocations , which have been implicated in carcinogenesismay causegenome rearrangements , such as deletions , duplications , and translocations , which have been implicated in carcinogenesis
in mutationsresultingin mutations
to mutationscan leadto mutations
to activation of the immune system either through increased neoantigens or activation of the STING pathwaycan leadto activation of the immune system either through increased neoantigens or activation of the STING pathway